Effects of atorvastatin and resveratrol against the experimental endometriosis; evidence for glucose and monocarboxylate transporters, neoangiogenesis

Ako Bahrami, Esmail Ayen, Mazdak Razi, Mehdi Behfar
Life sciences · 2021 · vol. 272 , pp. 119230 · doi:10.1016/j.lfs.2021.119230 · PMID:33600864 · W3133246967
article OA: closed CC0 ⤵ 17 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the effects of atorvastatin and resveratrol on experimental endometriosis, examining their impact on glucose and monocarboxylate transporters and neoangiogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Atorvastatin Endometriosis Resveratrol Animals Atorvastatin Atorvastatin Endometriosis Excitatory Amino Acid Transporter 2 Excitatory Amino Acid Transporter 2 Female Glucose Glucose Glucose Transporter Type 3 Glucose Transporter Type 3 Glycolysis Glycolysis Glycolysis Monocarboxylate Transport Protein 1 Monocarboxylic Acid Transporters Monocarboxylic Acid Transporters

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (57)

Cited by (17)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:24:49.034193+00:00
License: CC0 · commercial use OK